• Double HEDIS/STARS compliance rates for diabetic retinal assessment in 12 months
  • Most top healthcare plans now reimburse for retinal screenings
  • Simple four-step process is effective and affordable
  • One day diagnostic report—usually in 90 minutes
  • Like adding an ophthalmologist to your team

Product Specifications

Connects to EMR? Yes
For a list of EMR Partners click here

Top FAQs

View All FAQs

Top Documents

View All Documents

Breakthrough technology makes diabetic retinal exams SIMPLE, ACCURATE and AFFORDABLE for primary care.

See how the RetinaVue Network can help identify and reduce some of the leading causes of preventable blindness and vision-threatening conditions. 

Diabetic retinopathy is the leading cause of blindness among working-age adults.


RetinaVue Network enables screening for diabetic retinopathy in primary care, using SIMPLE four-step process:


RetinaVue 100 Imager

User Technique Video Guide 

Learn how to properly operate your device

Patient compliance rates can double in twelve months

RetinaVue Network can double patient compliance rates for diabetic retinal assessment in just 12 months; helping to preserve vision in patients with diabetes while also improving quality metrics for the practice.

Single Primary Care Clinic Retinal Assessment Compliance Results using the RetinaVue Network

Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and Retinal Images for Improving Diabetic Retinopathy Evaluation. Arch Intern Med. 2012; Oct 1: 1-2. 
* Patients with a Documented Retinal Assessment, %

For healthcare payors and providers who want to improve quality metrics associated with the management of patients with diabetes

  • RetinaVue is a scalable diabetic retinopathy screening program made simple for primary care practices and health-plan screening programs.

  • Welch Allyn RetinaVue Network is proven to double patient compliance rates, reduce screening costs and help preserve vision in patients with diabetes.

It is like adding an eye specialist to your team.

“In addition to identifying, classifying and documenting all levels of diabetic retinopathy from very mild to vision threatening, we have also been able to diagnose a surprising assortment of important systemic diseases based on RetinaVue fundus images—including papilledema, hypertension, macular degeneration (AMD), cancer and stroke.”


Chief Medical Officer, RetinaVue P.C.

Complete this form to learn more and schedule a demo

*The RV100 imager meets international fundus camera standards ISO 10940:2009, ISO 15004-1 and ISO 15004-2